Fig 1.
TB; tuberculosis: MDR-TB; multidrug-resistant tuberculosis: XDR-TB; extensively drug resistant tuberculosis.
Fig 2.
A predicted incidence monthly TB case by model of each diagnostic TB intervention.
Table 1.
Cost-effectiveness results.
Fig 3.
Efficiency frontier of molecular testing alternatives compared to conventional testing in general population.
Fig 4.
Tornado diagram.
Fig 5.
Cost-effectiveness plane based on a societal perspective.